1. Global Initiative for Аsthma. NHLB/WHO Workshop Report.-National Heart Lung Blood Institute, Publication number 02-3659, revised 2006. Пер. с англ. под ред. А.Г.Чучалина. М.: Атмосфера, 2007.
2. Hamid Q, Song Y, Kotsimbos TC et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100: 44–51.
3. Minshall ЕМ, Hogg JG, Hamid Q. Cytokine mRNA ехргеssion in asthma is not restrictеd to the large airways. J Аllergy Сlin Immunol 1998; 101: 386–90.
4. Саrrоll N, Cooke C, James А. The distribution of eosinophils аnd lymphocytes in the large аnd small airways of asthmatics. Еur Respir J 1997; 10: 292–300.
5. Faul JL, Tomtey VJ, Leonard С et al. Lung immunopathology in cases of sudden аsthma death. Еur Respir J 1997; 10: 301–7.
6. Kraft М, Djukanovic R, Wilson S et al. Аlvеоlаr tissue inflammation in asthma. Аm J Resp Crit Care Меd 1996; 154: 1505–10.
7. Weibel ER. Morphometry of the Ниmаn lung. New York: Асаdemic Pгess; 1963.
8. Van Brabant H, Cauberghs M, Verbeken E et al. Partitioning of pulmonary impedance in excised human and canine lungs. J Appl Physiol 1983; 55: 1733–42.
9. Wagner EM, Lui MC, Wainmann GG et al. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis 1990; 141: 584–8.
10. Hamid Q. Peripheral inflammation is more important than central inflammation. Respir Med 1997; 91: 11–2.
11. Haley KJ, Sunday ME, Wiggs BR et al. Inflammatory cell distribution within and along asthmatic airways. Am J Respir Crit Care Med 1998; 158: 565–72.
12. Saetta M, Di Stefano A, Rosina C et al. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143: 138–43.
13. Christodoulopoulos Р, Leuпg DY, Еlliot MW et al. Increased number of glucocorticoid receptor-beta-expressing cells in the airways in fatal asthma. J Allergy Сlin Immunol 2000; 146: 479–84.
14. Wenzel SЕ, Szefler SJ, Leung DY et al. Bronchoscopic evaluation of severe asthma. Persistent inflammafion associated with high-dose glucocorticoids. Аm J Respir Crit Саre Меd 1997; 156: 737–43.
15. Tashkin DP. The role of small airway inflammation in asthma. Allergy Asthma Proc 2002; 23 (4): 233–42.
16. Esmailpour N, Hogger Р, Rabe KF et al. Distributioп оf inhaled fluticasone propionate between human lung tissue аnd serum in vivo. Eur Respir J 1997; 10: 1496–9.
17. Kraft M. Part III: Location of asthma inflammation and the distal airways: clinical implications. Curr Med Res Opin 2007; 23 (Suppl. 3): S21–7.
18. Acerbi D, Brambilla G, Kottakis I. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology. Pulm Pharmacol Ther 2007; 20 (3): 290–303.
19. Bousquet J, Cantini L. Clinical studies in asthmatics with a new nonextra fine HFA formulation of beclometasone dipropionate (BDP Modulite). Respir Med 2002; 96 (Suppl. D): S17–27.
20. Farmer IS, Middle M, Savic J et al. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma. Respir Med 2000; 94 (1): 57–63.
21. Martin RJ. Therapeutic significance of distal airway inflammation in asthma. J Allergy Clin Immunol 2002; 109 (2 Suppl.): S447–60.
22. Dhillon S, Keating GM. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler. Drugs 2006; 66 (11): 1475–83.
23. Papi A, Paggiaro PL, Nicolini G et al. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J 2007; 29 (4): 682–9.
24. Papi A, Paggiaro P, Nicolini G et al. Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. Allergy 2007; 62 (10): 1182–8.